Literature DB >> 6373477

Effect of simultaneous administration of glucagon and insulin on renal function in patients with liver cirrhosis and ascites.

K Hattori, Y Hasumura, J Takeuchi.   

Abstract

Since glucagon and insulin (G/I) have been suggested to be hepatotrophic substances, the effect of G/I infusion on the ability to excrete water and sodium was tested in seven patients with cirrhosis and ascites (decompensated group), and compared with that in seven cirrhotics without ascites (compensated group). A constant infusion of 1 U glucagon and 10 U regular insulin over 2 hours daily for 14 days resulted in a significant improvement of prothrombin time in the decompensated group. Concomitantly, an increase in urine volume (62%, p less than 0.02) and a tendency toward an increase in urinary sodium excretion (68%, 0.05 less than p less than 0.1) were observed only in the decompensated group after the G/I infusion. In addition, these were associated with increases in creatinine clearance and osmotic clearance. These results suggest that glucagon and insulin merit further study in hepatorenal syndrome cases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6373477     DOI: 10.1007/bf02774647

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  14 in total

1.  THE KIDNEY IN CIRRHOSIS. II. DISORDERS OF RENAL FUNCTION.

Authors:  W P BALDUS; R N FEICHTER; W H SUMMERSKILL; J C HUNT; K G WAKIM
Journal:  Ann Intern Med       Date:  1964-03       Impact factor: 25.391

2.  The role of the kidney in Laennec's cirrhosis of the liver.

Authors:  S PAPPER
Journal:  Medicine (Baltimore)       Date:  1958-12       Impact factor: 1.889

3.  "Cirrhotic glomerulosclerosis," a renal lesion associated with hepatic cirrhosis.

Authors:  J M BLOODWORTH; S C SOMMERS
Journal:  Lab Invest       Date:  1959 Sep-Oct       Impact factor: 5.662

4.  Thrombotest. A new method for controlling anticoagulant therapy.

Authors:  P A OWREN
Journal:  Lancet       Date:  1959-11-07       Impact factor: 79.321

5.  The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood.

Authors:  T E Starzl; A Francavilla; C G Halgrimson; F R Francavilla; K A Porter; T H Brown; C W Putnam
Journal:  Surg Gynecol Obstet       Date:  1973-08

6.  Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma.

Authors:  R L Emanuel; J P Cain; G H Williams
Journal:  J Lab Clin Med       Date:  1973-04

7.  Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease.

Authors:  M H Koppel; J W Coburn; M M Mims; H Goldstein; J D Boyle; M E Rubini
Journal:  N Engl J Med       Date:  1969-06-19       Impact factor: 91.245

8.  Estimation of the functional reserve of human liver.

Authors:  F G Moody; L F Rikkers; J S Aldrete
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

9.  Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration.

Authors:  T E Starzl; K A Porter; N Kashiwagi
Journal:  Surg Gynecol Obstet       Date:  1975-12

10.  Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon.

Authors:  M L Bucher; M N Swaffield
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.